Diabetes drug similar to Ozempic helped slow progression of Parkinson’s disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson's diseaseSherbrooke Connectivity Imaging Lab | Getty ImagesA ...
Tag: Novo Nordisk A/S
Novo Nordisk’s $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ...
Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks.In health ...
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket ...
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado ...
Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.Victoria ...
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Cr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target ...
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. Victoria ...
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, ...
LVMH shares jump 8% as earnings point to luxury sector resilience
Bernard Arnault, Chairman and CEO of LVMH Moet Hennessy Louis Vuitton, speaks during a press conference to present the 2023 ...
